Solvonis Therapeutics plc (LON:SVNS)

London · Delayed Price · Currency is GBP · Price in GBX

0.2400

+0.0100 (4.35%)

At close: Mar 26, 2026

Revenue by Segment

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	May '21 May 31, 2021	May '20 May 31, 2020	May '19 May 31, 2019	May '18 May 31, 2018
Polymer Development and Production		587.00K	-	375.43K	520.00K	330.00K
Polymer Development and Production Growth		-	-	-27.80%	57.58%	1037.93%
Total		587.00K	-	375.43K	520.00K	330.00K
Total Growth		-	-	-27.80%	57.58%	1037.93%

Revenue by Geography

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	May '21 May 31, 2021	May '20 May 31, 2020	May '19 May 31, 2019	May '18 May 31, 2018
Slovenia		166.00K	127.00K	15.43K	214.00K	-
Slovenia Growth		30.71%	723.13%	-92.79%	-	-
Europe		355.00K	415.00K	274.29K	255.00K	-
Europe Growth		-14.46%	51.30%	7.56%	-	-
Rest of The World		66.00K	-	85.71K	51.00K	-
Rest of The World Growth		-	-	68.07%	-	-
Total		587.00K	542.00K	375.43K	520.00K	-
Total Growth		8.30%	44.37%	-27.80%	-	-

Source: S&P Global Market Intelligence.